Research
Therapeutic antibody protects against all three pathogenic human coronaviruses
The Brief
- Researchers at Georgia State University and collaborators developed a bispecific nanobody therapeutic antibody.
- The antibody neutralized SARS-CoV, SARS-CoV-2 and MERS-CoV, the three highly pathogenic human coronaviruses, according to the study.
- The study reports the antibody protected animals from viral infections.
Why it matters
A single antibody that works against three highly pathogenic coronaviruses could inform broader therapeutic strategies against future coronavirus outbreaks.
Who’s affected
- researchers working on coronavirus therapeutics
- public health planners concerned with emerging coronavirus threats
- #coronavirus
- #nanobody
- #antibody therapy
- #sars-cov-2
- #mers-cov
- #infectious disease
A therapeutic antibody (bispecific nanobody) developed by researchers at Georgia State University and collaborators neutralized all three highly pathogenic human coronaviruses (SARS-CoV, SARS-CoV-2 and MERS-CoV) and protected animals from viral infections, according to a study…